Evaluation The Projection Indices in Multiple Sclerosis Patients with Optic Neuritis and Its Relationship with The Severity of MS Disease

Document Type : Original Article

Authors

1 Department of Neurology, School of medicine, Ardabil university of medical science, Ardabil, Iran.

2 Department of Psychology, School of medicine, Ardabil university of medical science, Ardabil, Iran

3 Department of Community Medicine, School of medicine, Ardabil university of medical science, Ardabil, Iran.

4 School of medicine, Ardabil university of medical science, Ardabil, Iran.

10.22038/psj.2026.94183.1522

Abstract

Background:
The most common type of inflammatory and immune-mediated disease of the central nervous system is Multiple Sclerosis (MS). The Rorschach test is one of the most well-known evaluation tools for the assessment of broad and deep personality characteristics such as organization and personality function is among the unconscious defense mechanisms. Evaluation of projection indices of MS patients with optic neuritis and its relationship with MS disease severity.
 
methods:
The descriptive analytical study was done to evaluate the projection indices on 50 patients with multiple sclerosis who have optic neuritis using the Rorschach test. After examining the clinical history of the patients, those who had no history of psychiatric disorders and whose optic neuritis improved were selected for the study.
 
Results:
There was a significant difference between age groups in Zest and ZSUM indices, thus patients with age>50 had obtained higher scores. There was a significant difference between men and women in A and Ge indices, thus men had obtained higher scores.
Conclusions:
Adherence to treatment, quality of life of patients, communication with patients and understanding the risk of treatment are some important clinical issues that are influenced by the personality characteristics of MS patients.

Keywords

Main Subjects


  1. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112 :133-46. doi: 10.1093/brain/112.1.133.
  2. Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol 2009;66(9):1139-43. doi: 10.1001/archneurol.2009.190.
  3. Biousse V, Newman NJ. Diagnosis and clinical features of common optic neuropathies. Lancet Neurol 2016;15(13):1355-1367. doi: 10.1016/S1474-4422(16)30237-X.

4.Katsuki R, Inoue A, Indias S, Kurahara K, Kuwano N, Funatsu F, et al. Clarifying Deeper Psychological Characteristics of Hikikomori Using the Rorschach Comprehensive System: A Pilot Case–Control Study. Frontiers in psychiatry 2019; 10:412.

5.Ožura A, Erdberg P, Šega S. Personality characteristics of multiple sclerosis patients: A Rorschach investigation. Clinical neurology and neurosurgery 2010;112(7):629-32.

  1. Hansen KG. Rorschach Comprehensive System data for a sample of 75 Danish 9-year-old children: a pilot study. J Pers Assess 2007;89:S52-S56. doi: 10.1080/00223890701582947.
  2. Balottin L, Mannarini S, Candeloro D, Mita A, Chiappedi M, Balottin U. Rorschach Evaluation of Personality and Emotional Characteristics in Adolescents with Migraine Versus Epilepsy and Controls. Front Neurol 2018;9:160. doi: 10.3389/fneur.2018.00160.
  3. Kishimoto N, Yamamuro K, Iida J, Ota T, Tanaka S, Kyo M, et al. Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder. Neuropsychiatr Dis Treat 2016;12:2403-2410. doi: 10.2147/NDT.S116223.

9.Palmieri A, Kleinbub J.R, Mannarini S, Molinaro S, Castriotta C, Scocco P. Rorschach assessment in suicide survivors: focus on suicidal ideation. Frontiers in public health 2019;6:382-8.

  1. Giromini L, Viglione D.J, Brusadelli E, Lang M. Cross Cultural Validation of the Rorschach Developmental Index. Journal of Personality Assessment 2015;97(4): 348–353.
  2. Barišić J, Milosavljević M, Duišin D, Batinić B, Vujović S, Milovanović S. Assessment of self-perception of ms persons: pilot study of 50 patients. The Scientific World Journal 2014;2014:1-5.